Synthesis of clopidogrel impurity intermediate

A diastereomer and process technology, which is applied in the field of important intermediates for the preparation of clopidogrel, a highly active anti-platelet aggregation drug, can solve the problems of potential danger, long reaction time, large loss of raw materials, etc., and can achieve the operation cycle Short, easy to operate, good for yield

CN101747219AInactive Publication Date: 2010-06-23SHANGHAI ECUST BIOMEDICINE CO LTD
6 Cites 2 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Publication Date
2010-06-23
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to a process for resolving 2-substituted phenylglycine methyl ester (or acid) in high yield. S-(+)-o-chlorophenylglycine methyl ester is an important intermediate for preparing antiplatelet clopidogrel with high activity. R-(-)-o-chlorophenylglycine methyl ester is an important intermediate for preparing a clopidogrel related compound after liquid phase positioning. The process has the advantages of high utilization ratio of the raw material, higher purity of the product, short reaction time, low reaction temperature, higher yield, cyclic utilization of the solvent and the resolution reagent, fully utilization of the resolution reagent and the solvent, no three wastes discharge, environmental protection and the like.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The present invention relates to a high-yield resolution process for 2-substituted phenylglycine methyl esters (or acids), wherein S-(+)-o-chlorophenylglycine methyl esters are used to prepare clopidogrel, a drug with high activity against platelet aggregation important intermediates. R-(-)-o-chlorophenylglycine methyl ester is an important intermediate for the preparation of liquid-phase-localized impurities of clopidogrel.

[0002] The 2-substituted phenylglycine methyl ester and acid in the structural formula I prepared by the present invention are important non-natural amino acids with physiological activity, and are also important intermediates of the highly active anti-platelet aggregation drug clopidogrel.

[0003]

[0004] Structural Formula I

[0005] Here, R=H, alkyl (C 1 -C 4 ,benzene)

[0006] X = halogen, OR 1 、SR 1

[0007] here R 1 = H or alkane (C 1 -C 3 )

[0008] = Benzene and optionally substituted benzene Background t...

Examples

specific Embodiment 1

[0037] Add D-(-)-tartaric acid (6.6 g, 0.044 mol) and anhydrous methanol (64 ml) into a 100 ml three-necked flask, and stir at room temperature until they are completely dissolved. A mixed solution of 2-chlorophenylglycine methyl ester (8.0 g, 0.04 mol) and acetone (16 ml) was added dropwise into the reactor, and solids were precipitated during the dropwise addition, which took about 1 hour. After the dropwise addition, react at 28-32°C for 15-20 hours. After the reaction was cooled, stirring was continued for one hour. Suction filtration and filter cake drying to obtain dry solid (R)-(-)-2-chlorophenylglycine methyl ester tartrate, yield 89%, melting point 164-166°C (document: 163-167°C) optical rotation [α] D -86 0 (C=1, CH 3 Oh)

specific Embodiment 2

[0038] Add D-(-)-tartaric acid (6.6 g, 0.044 mol) and anhydrous methanol (64 ml) into a 100 ml three-necked flask, and stir at room temperature until they are completely dissolved. After adding catalytic amount of acetophenone, the mixed solution of 2-chlorophenylglycine methyl ester (8.0g, 0.04mol) and acetone (16ml) is added dropwise in the reactor, there is solid to separate out in the process of dropping, about 1 Hour. After the dropwise addition, react at 28-32°C for 5-6 hours. After the reaction was cooled, stirring was continued for 1 hour. Suction filtration and drying of the filter cake gave dry solid (R)-(-)-2-chlorophenylglycine methyl ester tartrate. Yield 92%, melting point 164-166°C (document: 163-167°C) optical rotation [α] D -88 0 (C=1, CH 3 OH).

specific Embodiment 3

[0039]Add D-(-)-tartaric acid (6.6 g, 0.044 mol) and anhydrous methanol (64 ml) into a 100 ml three-necked flask, and stir at room temperature until they are completely dissolved. After adding a catalytic amount of formaldehyde, a mixed solution of 2-chlorophenylglycine methyl ester (8.0g, 0.04mol) and acetone (16ml) was added dropwise into the reactor, and solids were precipitated during the dropwise addition, which took about one hour . After the dropwise addition, react at 28-32° C. for 10-20 hours. After the reaction was cooled, stirring was continued for one hour. Suction filtration and drying of the filter cake gave dry solid (R)-(-)-2-chlorophenylglycine methyl ester tartrate. Yield 85%, melting point 164-166°C (document: 163-167°C) optical rotation [α] D -88 0 (C=1, CH 3 OH).